University of Ferrara, Department of Clinical and Experimental Medicine, Pharmacology Section, 44100 Ferrara, Italy.
Expert Opin Investig Drugs. 2011 Dec;20(12):1591-609. doi: 10.1517/13543784.2011.627853. Epub 2011 Oct 22.
The adenosine receptors A(1), A(2A), A(2B) and A(3) are important and ubiquitous mediators of cellular signaling that play vital roles in protecting tissues and organs from damage. In particular, adenosine triggers tissue protection and repair by different receptor-mediated mechanisms, including increasing the oxygen supply:demand ratio, pre-conditioning, anti-inflammatory effects and the stimulation of angiogenesis.
The state of the art of the role of adenosine receptors which have been proposed as targets for drug design and discovery, in health and disease, and an overview of the ligands for these receptors in clinical development.
Selective ligands of A(1), A(2A), A(2B) and A(3) adenosine receptors are likely to find applications in the treatment of pain, ischemic conditions, glaucoma, asthma, arthritis, cancer and other disorders in which inflammation is a feature. The aim of this review is to provide an overview of the present knowledge regarding the role of these adenosine receptors in health and disease.
腺苷受体 A(1)、A(2A)、A(2B) 和 A(3) 是细胞信号转导的重要和普遍介质,在保护组织和器官免受损伤方面发挥着重要作用。特别是,腺苷通过不同的受体介导机制触发组织保护和修复,包括增加氧供应:需求比、预处理、抗炎作用和刺激血管生成。
作为药物设计和发现靶点的腺苷受体的最新研究进展,以及这些受体在临床开发中的配体概述。
A(1)、A(2A)、A(2B) 和 A(3) 腺苷受体的选择性配体可能在治疗疼痛、缺血性疾病、青光眼、哮喘、关节炎、癌症和其他以炎症为特征的疾病方面有应用。本综述的目的是提供对这些腺苷受体在健康和疾病中的作用的现有知识的概述。